在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

IDH2 Antibody

  • 中文名稱:
    IDH2兔多克隆抗體
  • 貨號:
    CSB-PA010990ESR2HU
  • 規格:
    ¥440
  • 圖片:
    • Western blot
      All lanes: IDH2 antibody at 5μg/ml
      Lane 1: Hela whole cell lysate
      Lane 2: Mouse heart tissue
      Secondary
      Goat polyclonal to rabbit IgG at 1/10000 dilution
      Predicted band size: 51, 46 kDa
      Observed band size: 51 kDa
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) IDH2 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 別名:
    D2HGA2 antibody; ICD-M antibody; IDH antibody; IDH2 antibody; IDHM antibody; IDHP_HUMAN antibody; IDP antibody; IDPM antibody; Isocitrate dehydrogenase [NADP], mitochondrial antibody; Isocitrate dehydrogenase 2 (NADP+), mitochondrial antibody; mNADP-IDH antibody; NADP(+)-specific ICDH antibody; Oxalosuccinate decarboxylase antibody
  • 宿主:
    Rabbit
  • 反應種屬:
    Human, Mouse
  • 免疫原:
    Recombinant Human Isocitrate dehydrogenase [NADP], mitochondrial protein (193-452AA)
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Non-conjugated
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    Antigen Affinity Purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA, WB
  • 推薦稀釋比:
    Application Recommended Dilution
    WB 1:500-1:2000
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Plays a role in intermediary metabolism and energy production. It may tightly associate or interact with the pyruvate dehydrogenase complex.
  • 基因功能參考文獻:
    1. pharmacogenetics: observations uncover a mechanism of acquired resistance to a targeted therapy and underscore the importance of 2-hydroxyglutarate production in the pathogenesis of IDH2-mutant malignancies PMID: 29950729
    2. We validated the presence of IDH2 R172 hotspot mutations and PIK3CA hotspot mutations in 100% and 67% of solid papillary breast carcinoma with reverse polarity tested, respectively PMID: 29603332
    3. Enasidenib reduces 2-hydroxyglutarate levels in patients with relapsed or refractory (R/R) acute myeloid leukemia harboring either IDH2-R140 or IDH2-R172 mutations PMID: 29243965
    4. IDH2 mutation is associated with glioma progression. PMID: 29016871
    5. This study furthers implementation of clinical genomics in MDS and identifies TP53 and IDH2 as targets for pre- or post-transplant therapy PMID: 28687222
    6. IDH2(mut) patients had a higher risk of leukemic transformation. The co-occurrence of DNMT3A or SRSF2 mutations was found to be increased in IDH2(mut) patients. IDH2 mutations were associated with significantly worse OS and LFS amongst patients with low-risk MDS by IPSS grouping. PMID: 29549529
    7. IDH2 R172 mutations may be the only variants present in angioimmunoblastic T-cell lymphoma because of their capacity to produce significant amounts of the oncometabolite 2-hydroxyglutarate in the cell of origin of this disease PMID: 27956631
    8. IDH2 mutation is associated with 1p19q co-deletion diffuse glioma. PMID: 28340142
    9. data confirm MLL-PTD and, to a lesser extent, FLT3-ITD as common events in +11 AML.6, 7, 8 However, the high mutation frequencies of U2AF1 and genes involved in methylation (DNMT3A, IDH2) have hitherto not been reported in +11 AML PMID: 27435003
    10. We demonstrate that the majority of histologically defined sinonasal undifferentiated carcinomas are characterized by IDH2 R172X mutations and overexpression of mutant protein PMID: 28084339
    11. The found of this study that IDH12 mutation status had greater impact than histological and other genomic features on miRNA expression patterns. PMID: 28091987
    12. demonstrate the presence of the IDH2 p.R172K/S mutation in patients with cutaneous localizations of angioimmunoblastic T-cell lymphomas. PMID: 28945625
    13. IDH2 mutation is associated with high-grade gliomas. PMID: 27353503
    14. these results suggest a potential relationship between SIRT3 enzymatic activity, IDH2-K413 acetylation-determined dimerization, and a cancer-permissive phenotype PMID: 28536275
    15. There are frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas. PMID: 28493366
    16. Results identified IDH2 rs11540478 as a new susceptibility locus for lung cancer. PMID: 27649069
    17. Functional studies demonstrated that IDH2 and PIK3CA hotspot mutations are likely drivers of solid papillary carcinoma with reverse polarity PMID: 27913435
    18. IDH2 mutation is associated with polycythemia vera and essential thrombocythemia. PMID: 27997717
    19. Mutations in some enzymes of the TCA cycle: Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH) and fumarate hydratase (FH) are associated with the accumulation of metabolites that are able to influence many aspects of cancer development and progression and for this reason are termed onco-metabolites. PMID: 27528759
    20. Only three IDH2(R172) mutation cases were detected in this series of patients with astrocytomas and oligodendrogliomas PMID: 27780605
    21. these data suggest that IDH2 may be a tumor suppressor in that its loss may promote malignant progression of gastric cancer via NF-kappaB-dependent increases in MMP7 activity. PMID: 26553362
    22. Genetic variants in IDH2 were found in patients with hematological malignancies. PMID: 27591990
    23. CASP8 rs3769823 and IDH2 rs4561444 were as the potential functional variants in high-linkage disequilibrium with these single nucleotide polymorphisms, respectively. The IDH2 mRNA levels were down-regulated in oesophageal squamous cell carcinoma. PMID: 26635288
    24. Results revealed that the expression of IDH2 was inversely correlated with pathological grade and metastasis in osteosarcoma and its downregulation may exacerbate malignant progression via increased NF-kappaB and MMP-9 activity. PMID: 26782630
    25. mechanistic studies of IDH2 mutations in gliomas (review) PMID: 26188014
    26. IDH2 mutation is associated with higher risk of malignant transformation in low-grade glioma. PMID: 26780338
    27. Results show that IDH2 is hypermethylated in glioma and the mutations are mutually exclusive with PTEN, P53 and ATRX mutations in the tumors. PMID: 27245697
    28. The Isocitrate dehydrogenase is mutated at a key active site arginine residue (Arg172 in IDH2) in many cancers, leading to the synthesis of the oncometabolite (R)-2-hydroxyglutarate (2HG). PMID: 26761588
    29. Down regulation of IDH2 may promote HCC cell invasion via NF-x03BA;B-dependent increases in MMP9 activity. IDH2 may be a potential therapeutic target for HCC PMID: 26646705
    30. With the advent of large-scale genome sequencing technology, molecular genetic alterations in IDH2 promoter have now been identified in the majority of oligodendrogliomas PMID: 26545048
    31. IDH2 mutations and their functions in human tumors (review) PMID: 26147657
    32. Glioblastomas with IDH1-m should be considered a different entity from the IDH1-wt, as their natural history and prognosis differ. In the near future we should be classified glioblastomas based on the presence of the IDH1 mutation PMID: 26194445
    33. The IDH2 mutations are associated with improved survival in patients with Glioblastomas. PMID: 26945349
    34. IDH2 mutation produced more 2-HG than IDH1 mutation. PMID: 26669865
    35. Authors suggest 2HG as an analytic marker (in serum, urine, or biopsies) predicting malignancy of breast cancer in all patients. PMID: 26007236
    36. report of clinicopathological characteristics of the gliomas with IDH2 mutations including two cases of primary GBM carrying a novel missense IDH2 mutation (c. 484C>T, p. P162S) PMID: 25495392
    37. suggest that mutations in isocitrate dehydrogenases IDH1/2 lead to a local block in osteogenic differentiation during skeletogenesis causing the development of benign cartilaginous tumors. PMID: 26046462
    38. IDH2 mutations are associated with normal cytogenetics and type A NPM1 mutations in Acute Myeloid Leukaemia. PMID: 25987093
    39. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma. PMID: 26268241
    40. IDH2 mutation is associated with response to therapy in anaplastic astrocytoma. PMID: 24993250
    41. IDH2 mutations are associated with myelodysplastic syndromes. PMID: 24936872
    42. IDH2 gene SNPs exhibited significant association with death risk in hepatocellular carcinoma patients. PMID: 25355558
    43. A review summarizes the function of mutated vs. wild-type IDH enzymes and the role of IDH2 mutations in gliomas. PMID: 25078896
    44. Gliomas were classified into five principal groups on the basis of three tumor markers including IDH2. The groups had different ages at onset, overall survival, and associations with germline variants. PMID: 26061753
    45. Isocitrate dehydrogenase 2 mutation is associated with infiltrative glioma. PMID: 24860178
    46. When normalized with the respective WT-IDH cells, the general metabolic shifts of MT-IDH1 and IDH2 were almost opposite. Lactate level was lower in MT-IDH2 cells which produced more 2-HG than MT-IDH1 cells. PMID: 25251602
    47. we propose the TCM compounds, precatorine and abrine, as potential candidates as lead compounds for further study in drug development process with the IDH2 R140Q mutant protein against cancer PMID: 24995286
    48. These results indicated lithium chloride could decrease the proliferation and migration potential of C6 glioma cells harboring IDH2 mutation. PMID: 24549719
    49. The recent discoveries reported here help understanding of the role of the IDH1/2 mutations in chondrosarcomas. IDH mutational status serves as a molecular signature to differentiate chondrosarcomas from other sarcomas with cartilaginous element. PMID: 24867810
    50. knowledge of the IDH mutation status has had significant translational implications, and diagnostic tools are being used to monitor its expression and function[Review] PMID: 23373447

    顯示更多

    收起更多

  • 相關疾病:
    D-2-hydroxyglutaric aciduria 2 (D2HGA2); Glioma (GLM)
  • 亞細胞定位:
    Mitochondrion.
  • 蛋白家族:
    Isocitrate and isopropylmalate dehydrogenases family
  • 數據庫鏈接:

    HGNC: 5383

    OMIM: 137800

    KEGG: hsa:3418

    STRING: 9606.ENSP00000331897

    UniGene: Hs.596461



主站蜘蛛池模板: 一本一本久久a久久综合精品蜜桃| 国语高潮无遮挡无码免费看| 3d成人h动漫网站入口| 亚洲欧美日韩国产国产a| 亚洲a∨无码国产精品久久网| 夜夜躁狠狠躁日日躁视频| 日日碰狠狠躁久久躁婷婷| 巨爆乳无码视频在线观看| 亚洲色婷婷六月亚洲婷婷6月| 色婷婷六月亚洲婷婷丁香| 午夜福利国产成人a∨在线观看| 成人网站免费高清视频在线观看| 国产无遮挡又黄又爽不要vip软件| 99热在线精品免费全部my| 爱色精品视频一区二区| 国产精品区免费视频| 亚洲乱亚洲乱妇无码麻豆| 精品无码av无码专区| 乱人伦中文字幕成人网站在线| 久久国产人妻一区二区免费| 人与狗精品aa毛片| 18禁无遮挡免费视频网站| 久久久久蜜桃精品成人片公司| 色偷偷人人澡久久超碰97| 中文字幕无码视频专区| 亚洲深深色噜噜狠狠爱网站| 婷婷五月日韩av永久免费| 狂野欧美激情性xxxx在线观看| 97丨九色丨国产人妻熟女| 无码国产精品一区二区免费式直播| 国产成人精品男人的天堂| 国产极品美女到高潮无套| 一区一区三区产品乱码亚洲| 中国真实偷乱视频| 国产亚洲精品aaaa片小说| 黑人玩弄人妻1区二区| 国产尤物人成免费观看| 永久免费看啪啪网址入口| 免费无码毛片一区二三区| 新国产精品视频福利免费| 国产精品爽爽va吃奶在线观看 |